Consultation on “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100: Guidance Document – Part C, Division 5 of the Food and Drug Regulations)
Data and Resources
Additional Info
| Field | Value |
|---|---|
| Last Updated | April 17, 2026, 21:22 (UTC) |
| Created | April 17, 2026, 21:22 (UTC) |
| criticality_level | [] |
| geographic_scope | [] |
| open_canada_collection | publication |
| open_canada_date_published | 2017-05-18 00:00:00 |
| open_canada_keywords | {"fr": ["consultation", "document d'orientation", "médicaments pour essais cliniques", "médicaments impliquant des sujets humains"], "en": ["consultation", "guidance document", "drugs for clinical-trials", "drugs involving human-subjects"]} |
| open_canada_subject | ["health_and_safety"] |
| sensitivity_level | unrestricted |
| title_fr | Consultation sur « Drogues destinées aux essais cliniques sur des sujets humains » (GUI-0100 : Document d’orientation – Titre 5 de la partie C du Règlement sur les aliments et drogues) |
| update_frequency | as_needed |